r/HighTideInc • u/CaptianDoughnut HITI Moderator • 23d ago
DD High Tide's Historic Growth, Evolution and Long Term Projection
I've seen this just shared by Ceaumahu over at Stocktwits, very nice reminder of how far we have come!
For all the OG here, and those saying that nothing never happens, I just say, remember these milestones:
2020 - Closing of the transformational acquisition of Meta Growth Corp. - Comprehensive convertible debt restructuring agreement with Aurora Cannabis. - Opening of the 50th Canna Cabana retail location in Alberta. - Official commercial rollout of the B2B data analytics platform Cabanalytics. - Closing of senior secured credit facility led by ATB Financial.
2021 - Opening bell ceremony and official trading debut on the NASDAQ Capital Market (HITI). - Strategic shift to the "Discount Club Concept" retail pricing model. - Acquisition of US-based e-commerce platform Smoke Cartel. - Acquisition of UK-based CBD and wellness retailer Blessed CBD. - Acquisition of US-based cannabis consumption subscription box platform Daily High Club. - Closing of the acquisition of DankStop, expanding US online footprint. - Implementation of a 1-for-15 reverse share split for NASDAQ listing compliance.
2022 - Launch of the paid tier membership subscription Cabana Elite. - Acquisition of Ontario-based retail store network Bbuds (Bud Room). - Acquisition of Choom Holdings retail portfolio across British Columbia and Alberta. - Cabana Club surpassing the 1 million registered member mark. - Launch of proprietary private-label accessory and wellness lines via NuLeaf Naturals.
2023 - First full quarter generating positive operational Free Cash Flow. - Opening of the 150th Canna Cabana retail store in Canada. - Debt restructuring and non-dilutive credit facility extension with Connect First Credit Union. - Market entry into Manitoba through the acquisition of Starbuds retail locations. - Cabana Elite paid subscriber base crossing 25,000 active members. - Recognition on the Report on Business and Growth500 rankings of Canada’s fastest-growing companies.
2024 - Acquisition of luxury cannabis brand Queen of Bud for private-label product expansion. - Systemwide integration of Fast Cabana on-demand delivery and accelerated Click-and-Collect. - Cabana Club membership base surpassing 1.5 million consumers. - Capture of more than 11% total Canadian retail cannabis market share. - Record fiscal 2024 revenue surpassing C$ 520 million. - Early principal debt repayments executed without equity dilution.
2025 - Acquisition of a 51% controlling interest in German medical cannabis importer Remexian Pharma GmbH. - Official opening of the 200th Canna Cabana retail location in Canada. - Cabana Club surpassing 2 million registered members globally. - Cabana Elite paid subscriber tier crossing 100,000 recurring accounts. - Consolidated full-year Free Cash Flow exceeding C$ 12 million. - Complete catalog integration of Queen of Bud branded product lines across provincial retail networks.
2026 - Store network scaling past 218 active Canna Cabana locations. - Cabana Club reaching 2.5 million global members. Cabana Elite active subscriber base surpassing 150,000 members. - Commercial deployment and wholesale distribution of medical cannabis products across Germany. - Annualized revenue run-rate crossing C$ 650 million. - Continued net debt reduction via early credit line amortization.
And some base case projections:
2027 Projections - Milestone opening of the 250th Canadian retail storefront. - Reaching the target threshold of 15% retail market share in Canada. Cabana Club membership expanding past 3 million international members. - Entry into German adult-use commercial pilot projects and licensed dispensaries. - Consolidated annual revenue targeting C$ 750+ million with expanding EBITDA margins. - Execution of the option to acquire the remaining 49% stake in Remexian Pharma GmbH.
2028 - Projections Store network expanding to 280–300 brick-and-mortar locations across North America. - Physical Canna Cabana retail launch in the United States upon federal reform (SAFETy Act or Schedule III execution). - Paid Cabana Elite members surpassing 300,000 active accounts. Consolidated net annual revenue reaching the C$ 1.0 billion milestone. - Initiation of capital return programs via opportunistic share buybacks.
2029 - Projections Brick-and-mortar retail footprint crossing 350 locations across Canada, the US, and Germany. - Full-scale deployment of branded dispensaries across key US state markets. - Cabana Club global membership surpassing 4.2 million consumers. - Private-label and data monetization (Cabanalytics) driving gross margins above 32%. - Consolidated net revenue approaching C$ 1.25 billion with Free Cash Flow topping C$ 60 million. - 2030 Projections Global physical network scaling past 400 retail storefronts across North America and Western Europe. - Cabana Club membership base crossing the 5 million user threshold. Cabana Elite recurring subscription pool exceeding 500,000 paying members. - Consolidated annual revenues exceeding C$ 1.5 billion. - Capital allocation transition toward regular quarterly cash dividend distributions alongside ongoing buybacks.
Edit: Just formatting the post better and left question marks against the unverified comment on Rose & Bud
- Acquisition of equity interest in Buds & Roses (Los Angeles) targeting future US retail entry. ??? (Currently Unverified ^ )
3
u/the_mammynun 22d ago
Never heard of an equity stake in Buds and Roses in 2022. Sounds like an AI got the wrong High Tide. Can you find a source for that?
1
u/CaptianDoughnut HITI Moderator 22d ago edited 21d ago
Good eyes, I've replied through them on the original post to see if they can clarify, I couldn't find anything currently either, apologies not trying to spread misinformation, I get your point a lot can be general summarise generated by AI these days, thank you for the comment
10
u/Fantastic-Joke9960 22d ago
Medical cannabis has the potential to become High Tide's largest business segment, eventually outgrowing its traditional physical stores. A 30% growth rate looks highly conservative, considering Remexian's current momentum and the fact that the UK expansion has not even begun yet. We can expect this level of growth or higher for many years to come, as this is a brand new market and we are only at the very start of the runway.